Dendreon (DNDN) Halted 10:30am (EST) Shares of Dendreon (DNDN, $35.87, no change) have been halted today due to pending news concerning its cancer drug, Provenge.  Many of our subscribers know we have been following this company for years and we were one of the first believers of the company whenRead more

More